News

Every year in June St. Petersburg becomes the international scientific center for doctors who are engaged in diagnostics and cancer therapy of mammary glands. The conference took place from 20-21 June.

 

The organizers of the conference were:

Ministry of Health of the Russian Federation;

North Western office of the Russian Academy of Medical Science;

Federal State Budgetary Institution for Oncology Scientific Research of the Ministry of Health;

Scientific Oncology Society of St. Petersburg and Leningrad region.

 

The opening of the conference was marked by speeches from:

Vice-president of the Russian Academy of Medical Science, chairman of the presidium of the North Western office of the Russian Academy of Medical Science, academician of the Russian Academy of Medical Science, professor G.A.Safronov;

Directors of the Federal State Budgetary Institution for Oncology Scientific Research, professor A.M.Belyaev;

Chief physician of the St. Petersburg City Oncological Clinic, professor G. M. Manikhas;

Head of the department of reproductive organ tumors of the Federal State Budgetary Institution for Oncology Scientific Research, member of the Russian Academy of Medical Science, professor V.F.Semiglazova.

 

The "White Nights" conference traditionally brings together the leading oncologists of Russia. However recently there has been growing attention for this event from foreign experts. This year reports were made by specialists from Great Britain, Italy, Finland, Lithuania, and Germany.

 

The main subjects of the conference were:

― Pharma-economics, innovations in diagnostics and breast cancer treatment;

― Molecular and biological, morphological and pathogenetic aspects of breast cancer;

― Neo-adjuvant and adjuvant medical therapy;

― Surgical treatment;

― X-ray radiological inspection and treatment.

 

During the conference there were specialized exhibitions in which representatives of Biovitrum advised participants about the opportunities and advantages of molecular and biological diagnostics for breast cancer using nanoString systems (USA), immunohistochemical diagnostics on Roche equipment (Switzerland), Monosan reagents (Netherlands) to use with Roche IGH-diagnostics and SpringBio’s product line (USA).  The use of this equipment and reagents makes it possible to carry out clinical diagnostics at a higher level and to estimate the probability of recurrence more precisely.

 

This conference was a scientific forum for oncologists during which leading experts acquainted participants with results of the latest scientific research, shared ideas and experience, and discussed new methods of diagnostics for breast cancer treatment. We hope next year to learn about new success in the area of diagnostics and effective treatment of oncological diseases of mammary glands.